X0206 3 2020-05-07 0 0001797336 Ayala Pharmaceuticals, Inc. AYLA 0001385115 Maimon Yossi OPPENHEIMER 4 REHOVOT L3 7670104 ISRAEL 0 1 0 0 CFO Stock Option 5.16 2029-03-15 Common Stock 70500 D Stock Option 6.50 2029-12-24 Common Stock 9460 D The option vests and becomes exercisable as to 25% on March 15, 2020 and as to the remainder of the shares in 12 equal quarterly installments thereafter. The option vests and becomes exercisable in 16 equal quarterly installments beginning on December 24, 2019. Exhibit 24 - Power of Attorney. /s/ Roni Mamluk, Ph.D., Attorney-in-Fact for Yossi Maimon, CPA, MBA 2020-05-07